{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T16:27:55Z","timestamp":1785774475232,"version":"3.56.0"},"reference-count":63,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2018,7,1]],"date-time":"2018-07-01T00:00:00Z","timestamp":1530403200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2018,7,1]],"date-time":"2018-07-01T00:00:00Z","timestamp":1530403200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000092","name":"U.S. National Library of Medicine","doi-asserted-by":"publisher","award":["RC2LM10994"],"award-info":[{"award-number":["RC2LM10994"]}],"id":[{"id":"10.13039\/100000092","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000057","name":"National Institute of General Medical Sciences","doi-asserted-by":"publisher","award":["GM113546"],"award-info":[{"award-number":["GM113546"]}],"id":[{"id":"10.13039\/100000057","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000057","name":"National Institute of General Medical Sciences","doi-asserted-by":"publisher","award":["R43LM012577"],"award-info":[{"award-number":["R43LM012577"]}],"id":[{"id":"10.13039\/100000057","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Psychopharmacology"],"published-print":{"date-parts":[[2018,9]]},"DOI":"10.1007\/s00213-018-4958-9","type":"journal-article","created":{"date-parts":[[2018,7,1]],"date-time":"2018-07-01T04:04:03Z","timestamp":1530417843000},"page":"2643-2650","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Molecular basis of atypicality of bupropion inferred from its receptor engagement in nervous system tissues"],"prefix":"10.1007","volume":"235","author":[{"given":"Eric J.","family":"Kim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Klara","family":"Felsovalyi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lauren M.","family":"Young","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sergey V.","family":"Shmelkov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael F.","family":"Grunebaum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0643-4497","authenticated-orcid":false,"given":"Timothy","family":"Cardozo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,7,1]]},"reference":[{"issue":"3","key":"4958_CR1","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1097\/JCP.0000000000000329","volume":"35","author":"S Alberti","year":"2015","unstructured":"Alberti S, Chiesa A, Andrisano C, Serretti A (2015) Insomnia and somnolence associated with second-generation antidepressants during the treatment of major depression: a meta-analysis. J Clin Psychopharmacol 35(3):296\u2013303","journal-title":"J Clin Psychopharmacol"},{"issue":"1","key":"4958_CR2","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/j.clinthera.2011.11.024","volume":"34","author":"HD Anderson","year":"2012","unstructured":"Anderson HD, Pace WD, Libby AM, West DR, Valuck RJ (2012) Rates of 5 common antidepressant side effects among new adult and adolescent cases of depression: a retrospective US claims study. Clin Ther 34(1):113\u2013123","journal-title":"Clin Ther"},{"issue":"1\u20133","key":"4958_CR3","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/j.jad.2005.08.016","volume":"89","author":"M Argyel\u00e1n","year":"2005","unstructured":"Argyel\u00e1n M, Szab\u00f3 Z, Kany\u00f3 B, Tan\u00e1cs A, Kov\u00e1cs Z, Janka Z, P\u00e1vics L (2005) Dopamine transporter availability in medication free and in bupropion treated depression: a 99mTc-TRODAT-1 SPECT study. J Affect Disord 89(1\u20133):115\u2013123","journal-title":"J Affect Disord"},{"issue":"11","key":"4958_CR4","doi-asserted-by":"publisher","first-page":"2098","DOI":"10.1016\/j.biocel.2009.05.015","volume":"41","author":"HR Arias","year":"2009","unstructured":"Arias HR (2009) Is the inhibition of nicotinic acetylcholine receptors by bupropion involved in its clinical actions? Int J Biochem Cell Biol 41(11):2098\u20132108","journal-title":"Int J Biochem Cell Biol"},{"issue":"4","key":"4958_CR5","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1111\/j.1600-0447.1985.tb02531.x","volume":"71","author":"J Beck-Friis","year":"1985","unstructured":"Beck-Friis J, Kjellman BF, Aperia B, Und\u00e9n F, von Rosen D, Ljunggren JG, Wetterberg L (1985) Serum melatonin in relation to clinical variables in patients with major depressive disorder and a hypothesis of a low melatonin syndrome. Acta Psychiatr Scand 71(4):319\u2013330","journal-title":"Acta Psychiatr Scand"},{"issue":"5","key":"4958_CR6","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1111\/dar.12048","volume":"32","author":"M Brensilver","year":"2013","unstructured":"Brensilver M, Heinzerling KG, Shoptaw S (2013) Pharmacotherapy of amphetamine-type stimulant dependence: an update. Drug Alcohol Rev 32(5):449\u2013460","journal-title":"Drug Alcohol Rev"},{"issue":"7","key":"4958_CR7","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1176\/ajp.142.7.811","volume":"142","author":"R Brown","year":"1985","unstructured":"Brown R, Kocsis JH, Caroff S, Amsterdam J, Winokur A, Stokes PE, Frazer A (1985) Differences in nocturnal melatonin secretion between melancholic depressed patients and control subjects. Am J Psychiatry 142(7):811\u2013816","journal-title":"Am J Psychiatry"},{"issue":"4","key":"4958_CR8","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1007\/BF00733786","volume":"7","author":"DP Cardinali","year":"1987","unstructured":"Cardinali DP, Vacas MI (1987) Cellular and molecular mechanisms controlling melatonin release by mammalian pineal glands. Cell Mol Neurobiol 7(4):323\u2013337","journal-title":"Cell Mol Neurobiol"},{"issue":"2","key":"4958_CR9","doi-asserted-by":"publisher","DOI":"10.1038\/tp.2017.6","volume":"7","author":"T Cardozo","year":"2017","unstructured":"Cardozo T, Shmelkov E, Felsovalyi K, Swetnam J, Butler T, Malaspina D, Shmelkov SV (2017) Chemistry-based molecular signature underlying the atypia of clozapine. Transl Psychiatry 7(2):e1036","journal-title":"Transl Psychiatry"},{"issue":"1","key":"4958_CR10","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/S0022-3565(25)32266-4","volume":"215","author":"BR Cooper","year":"1980","unstructured":"Cooper BR, Hester TJ, Maxwell RA (1980) Behavioral and biochemical effects of the antidepressant bupropion (Wellbutrin): evidence for selective blockade of dopamine uptake in vivo. J Pharmacol Exp Ther 215(1):127\u2013134","journal-title":"J Pharmacol Exp Ther"},{"key":"4958_CR11","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1016\/B978-0-12-420118-7.00013-5","volume":"69","author":"PA Crooks","year":"2014","unstructured":"Crooks PA, Bardo MT, Dwoskin LP (2014) Nicotinic receptor antagonists as treatments for nicotine abuse. Adv Pharmacol 69:513\u2013551","journal-title":"Adv Pharmacol"},{"issue":"2","key":"4958_CR12","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1016\/S0022-3565(24)29424-6","volume":"298","author":"JF Cryan","year":"2001","unstructured":"Cryan JF, Dalvi A, Jin SH, Hirsch BR, Lucki I, Thomas SA (2001) Use of dopamine-beta-hydroxylase-deficient mice to determine the role of norepinephrine in the mechanism of action of antidepressant drugs. J Pharmacol Exp Ther 298(2):651\u2013657","journal-title":"J Pharmacol Exp Ther"},{"issue":"3","key":"4958_CR13","doi-asserted-by":"publisher","first-page":"423","DOI":"10.12740\/PP\/30455","volume":"49","author":"E Dopiera\u0142a","year":"2015","unstructured":"Dopiera\u0142a E, Rybakowski J (2015) Sleep deprivation as a method of chronotherapy in the treatment of depression. Psychiatr Pol 49(3):423\u2013433","journal-title":"Psychiatr Pol"},{"issue":"12","key":"4958_CR14","doi-asserted-by":"publisher","first-page":"994","DOI":"10.1038\/sj.mp.4001314","volume":"8","author":"B Eisensamer","year":"2003","unstructured":"Eisensamer B, Rammes G, Gimpl G, Shapa M, Ferrari U, Hapfelmeier G, Bondy B, Parsons C, Gilling K, Zieglg\u00e4nsberger W, Holsboer F, Rupprecht R (2003) Antidepressants are functional antagonists at the serotonine type 3 (5-HT3) receptor. Mol Psychiatry 8(12):994\u20131007","journal-title":"Mol Psychiatry"},{"issue":"2","key":"4958_CR15","first-page":"81","volume":"92","author":"D Elena","year":"2015","unstructured":"Elena D, Benny BA, Connie S (2015) Emerging mechanisms and treatments for depression beyond SSRIs and SNRIs. Biochem Pharmacol 92(2):81\u201397","journal-title":"Biochem Pharmacol"},{"key":"4958_CR16","unstructured":"Eli Lilly and Company (2017) Cymbalta (duloxetine hydrochloride) delayed-release capsules prescribing information.\u00a0Retrieved from http:\/\/pi.lilly.com\/us\/cymbalta-pi.pdf"},{"issue":"8","key":"4958_CR17","doi-asserted-by":"publisher","first-page":"1202","DOI":"10.1016\/j.neuropharm.2011.07.009","volume":"61","author":"J Garc\u00eda-Colunga","year":"2011","unstructured":"Garc\u00eda-Colunga J, Godoy-Garc\u00eda U, V\u00e1squez-G\u00f3mez E (2011) Interaction of bupropion and zinc with neuronal nicotinic acetylcholine receptors. Neuropharmacology 61(8):1202\u20131209","journal-title":"Neuropharmacology"},{"key":"4958_CR18","doi-asserted-by":"publisher","first-page":"D1100","DOI":"10.1093\/nar\/gkr777","volume":"40","author":"A Gaulton","year":"2012","unstructured":"Gaulton A, Bellis LJ, Bento AP, Chambers J, Davies M, Hersey A, Light Y, McGlinchey S, Michalovich D, al-Lazikani B, Overington JP (2012) ChEMBL: a large-scale bioactivity database for drug discovery. Nucleic Acids Res 40:D1100\u2013D 1107","journal-title":"Nucleic Acids Res"},{"issue":"1","key":"4958_CR19","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1007\/s00213-011-2260-1","volume":"217","author":"R Ghanbari","year":"2011","unstructured":"Ghanbari R, El Mansari M, Blier P (2011) Enhancement of serotonergic and noradrenergic neurotransmission in the rat hippocampus by sustained administration of bupropion. Psychopharmacology 217(1):61\u201373","journal-title":"Psychopharmacology"},{"issue":"3","key":"4958_CR20","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1017\/S0033291700015099","volume":"14","author":"JC Gillin","year":"1984","unstructured":"Gillin JC, Sitaram N (1984) Rapid eye movement (REM) sleep: cholinergic mechanisms. Psychol Med 14(3):501\u2013506","journal-title":"Psychol Med"},{"issue":"1","key":"4958_CR21","doi-asserted-by":"publisher","first-page":"900","DOI":"10.1038\/s41598-017-01088-6","volume":"7","author":"S Han","year":"2017","unstructured":"Han S, Yang SH, Kim JY, Mo S, Yang E, Song KM, Ham BJ, Mechawar N, Turecki G, Lee HW, Kim H (2017) Down-regulation of cholinergic signaling in the habenula induces anhedonia-like behavior. Sci Rep 7(1):900","journal-title":"Sci Rep"},{"issue":"2","key":"4958_CR22","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1213\/ANE.0000000000000540","volume":"120","author":"H Hoshino","year":"2015","unstructured":"Hoshino H, Obata H, Nakajima K, Mieda R, Saito S (2015) The antihyperalgesic effects of intrathecal bupropion, a dopamine and noradrenaline reuptake inhibitor, in a rat model of neuropathic pain. Anesth Analg 120(2):460\u2013466","journal-title":"Anesth Analg"},{"issue":"2 suppl","key":"4958_CR23","doi-asserted-by":"publisher","first-page":"11","DOI":"10.2165\/00003495-200262002-00002","volume":"62","author":"AJ Johnston","year":"2002","unstructured":"Johnston AJ, Ascher J, Leadbetter R, Schmith VD, Patel DK, Durcan M, Bentley B (2002) Pharmacokinetic optimisation of sustained-release bupropion for smoking cessation. Drugs 62(2 suppl):11\u201324","journal-title":"Drugs"},{"issue":"4","key":"4958_CR24","first-page":"379","volume":"142","author":"BE Jones","year":"2004","unstructured":"Jones BE (2004) Paradoxical REM sleep promoting and permitting neuronal networks. Arch Ital Biol 142(4):379\u2013396","journal-title":"Arch Ital Biol"},{"issue":"11","key":"4958_CR25","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1016\/j.tips.2005.09.009","volume":"26","author":"BE Jones","year":"2005","unstructured":"Jones BE (2005a) From waking to sleeping: neuronal and chemical substrates. Trends Pharmacol Sci 26(11):578\u2013586","journal-title":"Trends Pharmacol Sci"},{"key":"4958_CR26","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1016\/B0-72-160797-7\/50018-5","volume-title":"Principles and practice of sleep medicine","author":"BE Jones","year":"2005","unstructured":"Jones BE (2005b) Basic mechanisms of sleep-wake states. In: Kryger MH (ed) Principles and practice of sleep medicine, 4th edn. WB Saunders Company, Philadelphia, pp 136\u2013153","edition":"4"},{"issue":"Database issue","key":"4958_CR27","doi-asserted-by":"publisher","first-page":"D1091","DOI":"10.1093\/nar\/gkt1068","volume":"42","author":"V Law","year":"2014","unstructured":"Law V, Knox C, Djoumbou Y, Jewison T, Guo AC, Liu Y, Maciejewski A, Arndt D, Wilson M, Neveu V, Tang A, Gabriel G, Ly C, Adamjee S, Dame ZT, Han B, Zhou Y, Wishart DS (2014) DrugBank 4.0: shedding new light on drug metabolism. Nucleic Acids Res 42(Database issue):D1091\u2013D1097","journal-title":"Nucleic Acids Res"},{"issue":"8","key":"4958_CR28","doi-asserted-by":"publisher","first-page":"800","DOI":"10.1016\/S0006-3223(02)01834-6","volume":"54","author":"SM Learned-Coughlin","year":"2003","unstructured":"Learned-Coughlin SM, Bergstorm M, Savitcheva I, Ascher J, Schmith VD, Langstorm B (2003) In vivo activity of bupropion at the human dopamine transporter as measured by positron emission tomography. Biol Psychiatry 54(8):800\u2013805","journal-title":"Biol Psychiatry"},{"issue":"5","key":"4958_CR29","doi-asserted-by":"publisher","first-page":"1180","DOI":"10.1097\/ALN.0b013e31820efb19","volume":"114","author":"D-Y Liang","year":"2011","unstructured":"Liang D-Y, Li X, Clark JD (2011) 5-Hydroxytryptamine type 3 receptor modulates opioid-induced hyperalgesia and tolerance in mice. Anesthesiology 114(5):1180\u20131189","journal-title":"Anesthesiology"},{"issue":"2","key":"4958_CR30","first-page":"46","volume":"6","author":"S Malhotra","year":"2004","unstructured":"Malhotra S, Sawhney G, Pandhi P (2004) The therapeutic potential of melatonin: a review of the science. MedGenMed 6(2):46","journal-title":"MedGenMed"},{"issue":"4","key":"4958_CR31","doi-asserted-by":"publisher","first-page":"pyu050","DOI":"10.1093\/ijnp\/pyu050","volume":"18","author":"ME Mansari","year":"2015","unstructured":"Mansari ME, Manta S, Oosterhof C, El Iskandrani KS, Chenu F, Shim S, Blier P (2015) Restoration of serotonin neuronal firing following long-term administration of bupropion but not paroxetine in olfactory bulbectomized rats. Int J Neuropsychopharmacol 18(4):pyu050","journal-title":"Int J Neuropsychopharmacol"},{"issue":"1","key":"4958_CR32","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1007\/s00213-002-1166-3","volume":"163","author":"JH Meyer","year":"2002","unstructured":"Meyer JH, Goulding VS, Wilson AA, Hussey D, Christensen BK, Houle S (2002) Bupropion occupancy of the dopamine transporter is low during clinical treatment. Psychopharmacology 163(1):102\u2013105","journal-title":"Psychopharmacology"},{"issue":"4","key":"4958_CR33","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1016\/0006-3223(88)90291-0","volume":"23","author":"A Miles","year":"1988","unstructured":"Miles A, Philbrick DRS (1988) Melatonin and psychiatry. Biol Psychiatry 23(4):405\u2013425","journal-title":"Biol Psychiatry"},{"issue":"3","key":"4958_CR34","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.1124\/jpet.102.033852","volume":"302","author":"DK Miller","year":"2002","unstructured":"Miller DK, Sumithran SP, Dwoskin LP (2002) Bupropion inhibits nicotine-evoked [(3)H]overflow from rat striatal slices preloaded with [(3)H]dopamine and from rat hippocampal slices preloaded with [(3)H]norepinephrine. J Pharmacol Exp Ther 302(3):1113\u20131122","journal-title":"J Pharmacol Exp Ther"},{"issue":"1\u20132","key":"4958_CR35","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/S0006-8993(97)01459-5","volume":"786","author":"Y Nakagawa","year":"1998","unstructured":"Nakagawa Y, Ishima T, Takashima T (1998) The 5-HT3 receptor agonist attenuates the action of antidepressants in the 3 forced swim test in rats. Brain Res 786(1\u20132):189\u2013193","journal-title":"Brain Res"},{"key":"4958_CR36","unstructured":"National Center for Health Statistics (2017) Therapeutic drug use. https:\/\/www.cdc.gov\/nchs\/fastats\/drug-use-therapeutic.htm . Published May 3, Accessed 8 Mar 2018"},{"issue":"5","key":"4958_CR37","first-page":"661","volume":"10","author":"JP Oli\u00e9","year":"2007","unstructured":"Oli\u00e9 JP, Kasper S (2007) Efficacy of agomelatine, a MT1\/MT2 receptor agonist with 5-HT2C antagonistic properties, in major depressive disorder. Int J Neuropsychopharmacol 10(5):661\u2013673","journal-title":"Int J Neuropsychopharmacol"},{"issue":"4","key":"4958_CR38","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1016\/0168-0102(94)00871-C","volume":"21","author":"T Osaka","year":"1995","unstructured":"Osaka T, Matsumura H (1995) Noradrenaline inhibits preoptic sleep-active neurons through ct2-receptors in the rat. Neurosci Res 21(4):323\u2013330","journal-title":"Neurosci Res"},{"issue":"Pt A","key":"4958_CR39","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.neuropharm.2016.09.021","volume":"113","author":"A Pandhare","year":"2017","unstructured":"Pandhare A, Pappu AS, Wilms H, Blanton MP, Jansen M (2017) The antidepressant bupropion is a negative allosteric modulator of serotonin type 3A receptors. Neuropharmacology 113(Pt A):89\u201399","journal-title":"Neuropharmacology"},{"issue":"1","key":"4958_CR40","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s00213-010-1932-6","volume":"212","author":"NS Philip","year":"2010","unstructured":"Philip NS, Carpenter LL, Tyrka AR, Price LH (2010) Nicotinic acetylcholine receptors and depression: a review of the preclinical and clinical literature. Psychopharmacology 212(1):1\u201312","journal-title":"Psychopharmacology"},{"issue":"2","key":"4958_CR41","doi-asserted-by":"publisher","first-page":"652","DOI":"10.1152\/japplphysiol.01058.2002","volume":"95","author":"MF Piacentini","year":"2003","unstructured":"Piacentini MF, Clinckers R, Meeusen R, Sarre S, Ebinger G, Michotte Y (2003) Effect of bupropion on hippocampal neurotransmitters and on peripheral hormonal concentrations in the rat. J Appl Physiol 95(2):652\u2013656","journal-title":"J Appl Physiol"},{"key":"4958_CR42","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1007\/978-3-642-18500-7_9","volume-title":"Selective serotonin reuptake inhibitors. In: Antidepressants: Past, Present and Future","author":"SH Preskorn","year":"2004","unstructured":"Preskorn SH, Ross R, Stanga CY (2004) Selective serotonin reuptake inhibitors. In: Antidepressants: Past, Present and Future. Springer, Berlin, pp 241\u2013262"},{"issue":"2","key":"4958_CR43","doi-asserted-by":"crossref","first-page":"239","DOI":"10.5665\/sleep.3388","volume":"37","author":"RE Roberts","year":"2014","unstructured":"Roberts RE, Duong HT (2014) The prospective association between sleep deprivation and depression among adolescents. Sleep 37(2):239\u2013244","journal-title":"Sleep"},{"issue":"3","key":"4958_CR44","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1007\/BF02246105","volume":"117","author":"RJ Rodgers","year":"1995","unstructured":"Rodgers RJ, Cole JC, Tredwell JM (1995) Profile of action of 5.HT3 receptor antagonists, ondansetron and WAY 100289, in the elevated plus-maze test of anxiety of mice. Psychopharmacology 117(3):306\u2013312","journal-title":"Psychopharmacology"},{"issue":"2","key":"4958_CR45","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1080\/00401706.1983.10487848","volume":"25","author":"B Rosner","year":"1983","unstructured":"Rosner B (1983) Percentage points for a generalized ESD many outlier procedure. Technometrics 25(2):165\u2013172","journal-title":"Technometrics"},{"issue":"10","key":"4958_CR46","first-page":"677","volume":"18","author":"M Roychoudhury","year":"1996","unstructured":"Roychoudhury M, Kulkarni SK (1996) Prevention of morphine discontinuation phenomenon in mice by ondansetron, a selective 5-HT3 antagonist. Methods Find Exp Clin Pharmacol 18(10):677\u2013683","journal-title":"Methods Find Exp Clin Pharmacol"},{"issue":"29","key":"4958_CR47","doi-asserted-by":"publisher","first-page":"9789","DOI":"10.1523\/JNEUROSCI.0476-14.2014","volume":"34","author":"PY Shih","year":"2014","unstructured":"Shih PY, Engle SE, Oh G, Deshpande P, Puskar NL, Lester HA, Drenan RM (2014) Differential expression and function of nicotinic acetylcholine receptors in subdivisions of medial habenula. J Neurosci 34(29):9789\u20139802","journal-title":"J Neurosci"},{"key":"4958_CR48","doi-asserted-by":"publisher","first-page":"371","DOI":"10.3389\/fphys.2015.00371","volume":"6","author":"E Shmelkov","year":"2015","unstructured":"Shmelkov E, Grigoryan A, Swetnam J, Xin J, Tivon D, Shmelkov SV, Cardozo T (2015) Historeceptomic fingerprints for drug-like compounds. Front Physiol 6:371","journal-title":"Front Physiol"},{"issue":"6","key":"4958_CR49","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1038\/sj.mp.4001035","volume":"7","author":"RD Shytle","year":"2002","unstructured":"Shytle RD, Silver AA, Lukas RJ, Newman MB, Sheehan DV, Sanberg PR (2002) Nicotinic acetylcholine receptors as targets for antidepressants. Mol Psychiatry 7(6):525\u2013535","journal-title":"Mol Psychiatry"},{"issue":"12","key":"4958_CR50","doi-asserted-by":"publisher","first-page":"2634","DOI":"10.1016\/j.cellsig.2013.08.025","volume":"25","author":"NS Singh","year":"2013","unstructured":"Singh NS, Paul RK, Ramamoorthy A, Torjman MC, Moaddel R, Bernier M, Wainer IW (2013) Nicotinic acetylcholine receptor antagonists alter the function and expression of serine racemase in PC-12 and 1321N1 cells. Cell Signal 25(12):2634\u20132645","journal-title":"Cell Signal"},{"issue":"4","key":"4958_CR51","doi-asserted-by":"publisher","first-page":"e0149499","DOI":"10.1371\/journal.pone.0149499","volume":"11","author":"Nagendra S. Singh","year":"2016","unstructured":"Singh NS, Rutkowska E, Plazinska A, Khadeer M, Moaddel R, Jozwiak K, Bernier M, Wainer IW (2016) Ketamine metabolites enantioselectively decrease intracellular D-serine concentrations in PC-12 cells. PLoS ONE 11(4):e0149499","journal-title":"PLOS ONE"},{"issue":"1","key":"4958_CR52","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/S0022-3565(24)38905-0","volume":"295","author":"JE Slemmer","year":"2000","unstructured":"Slemmer JE, Martin BR, Damaj MI (2000) Bupropion is a nicotinic antagonist. J Pharmacol Exp Ther 295(1):321\u2013327","journal-title":"J Pharmacol Exp Ther"},{"issue":"4","key":"4958_CR53","doi-asserted-by":"publisher","first-page":"159","DOI":"10.4088\/PCC.v06n0403","volume":"6","author":"SM Stahl","year":"2004","unstructured":"Stahl SM, Pradko JF, Haight BR, Modell JG, Rockett CB, Learned-Coughlin S (2004) A review of the neuropharmacology of bupropion, a dual norepinephrine and dopamine reuptake inhibitor. Prim Care Companion J Clin Psychiatry 6(4):159\u2013166","journal-title":"Prim Care Companion J Clin Psychiatry"},{"issue":"9","key":"4958_CR54","doi-asserted-by":"publisher","first-page":"732","DOI":"10.1017\/S1092852900019726","volume":"10","author":"SM Stahl","year":"2005","unstructured":"Stahl SM, Grady MM, Moret C, Briley M (2005) SNRIs: their pharmacology, clinical efficacy, and tolerability in comparison with other classes of antidepressants. CNS Spectr 10(9):732\u2013747","journal-title":"CNS Spectr"},{"issue":"2\u20133","key":"4958_CR55","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1016\/S0014-2999(97)01393-9","volume":"340","author":"M Tatsumi","year":"1997","unstructured":"Tatsumi M, Groshan K, Blakely RD, Richelson E (1997) Pharmacological profile of antidepressants and related compounds at human monoamine transporters. Eur J Pharmacol 340(2\u20133):249\u2013258","journal-title":"Eur J Pharmacol"},{"issue":"4","key":"4958_CR56","doi-asserted-by":"publisher","first-page":"1430","DOI":"10.1073\/pnas.90.4.1430","volume":"90","author":"LH Tecott","year":"1993","unstructured":"Tecott LH, Maricq AV, Julius D (1993) Nervous system distribution of the serotonin 5-HT3 receptor mRNA. Proc Natl Acad Sci U S A 90(4):1430\u20131434","journal-title":"Proc Natl Acad Sci U S A"},{"key":"4958_CR57","unstructured":"U.S. Department of Health and Human Services (2015) National Institutes of Health, National Institute of Mental Health, Depression. Publication No. 15\u20133561, pp 1\u201332, https:\/\/www.nimh.nih.gov\/health\/publications\/depression-what-you-need-to- know\/depression-what-you-need-to-know-pdf_151827.pdf"},{"key":"4958_CR58","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/j.ejphar.2014.06.059","volume":"740","author":"E V\u00e1squez-G\u00f3mez","year":"2014","unstructured":"V\u00e1squez-G\u00f3mez E, Arias HR, Feuerbach D, Miranda-Morales M, Mihailescu S, Targowska-Duda KM, Jozwiak K, Garc\u00eda-Colunga J (2014) Bupropion-induced inhibition of \u03b17 nicotinic acetylcholine receptors expressed in heterologous cells and neurons from dorsal raphe nucleus and hippocampus. Eur J Pharmacol 740:103\u2013111","journal-title":"Eur J Pharmacol"},{"key":"4958_CR59","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1017\/S0033291717002781","volume":"48","author":"AH Weinberger","year":"2017","unstructured":"Weinberger AH, Gbedemah M, Martinez AM, Nash D, Galea S, Goodwin RD (2017) Trends in depression prevalence in the USA from 2005 to 2015: widening disparities in vulnerable groups. Psychol Med 48:1\u201310. https:\/\/doi.org\/10.1017\/S0033291717002781","journal-title":"Psychol Med"},{"key":"4958_CR60","unstructured":"World Health Organization (2017) Depression. http:\/\/www.who.int\/mediacentre\/factsheets\/fs369\/en\/ . Published February 2017. Accessed January 27, 2018"},{"issue":"11","key":"4958_CR61","doi-asserted-by":"publisher","first-page":"R130","DOI":"10.1186\/gb-2009-10-11-r130","volume":"10","author":"C Wu","year":"2009","unstructured":"Wu C, Orozco C, Boyer J, Leglise M, Goodale J, Batalov S, Hodge CL, Haase J, Janes J, Huss JW, Su AI (2009) BioGPS: an extensible and customizable portal for querying and organizing gene annotation resources. Genome Biol 10(11):R130","journal-title":"Genome Biol"},{"key":"4958_CR62","doi-asserted-by":"publisher","first-page":"D561","DOI":"10.1093\/nar\/gks1114","volume":"41","author":"C Wu","year":"2013","unstructured":"Wu C, MacLeod I, Su AI (2013) BioGPS and MyGene.info: organizing online, gene-centric information. Nucleic Acids Res 41:D561\u2013D565","journal-title":"Nucleic Acids Res"},{"issue":"13","key":"4958_CR63","doi-asserted-by":"publisher","first-page":"4946","DOI":"10.1523\/JNEUROSCI.18-13-04946.1998","volume":"18","author":"H Yamada","year":"1998","unstructured":"Yamada H, Ogura A, Koizumi S, Yamaguchi A, Moriyama Y (1998) Acetylcholine triggers L-glutamate exocytosis via nicotinic receptors and inhibits melatonin synthesis in rat pinealocytes. J Neurosci 18(13):4946\u20134952","journal-title":"J Neurosci"}],"container-title":["Psychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00213-018-4958-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00213-018-4958-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00213-018-4958-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,5]],"date-time":"2025-07-05T13:36:53Z","timestamp":1751722613000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00213-018-4958-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,7,1]]},"references-count":63,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2018,9]]}},"alternative-id":["4958"],"URL":"https:\/\/doi.org\/10.1007\/s00213-018-4958-9","relation":{},"ISSN":["0033-3158","1432-2072"],"issn-type":[{"value":"0033-3158","type":"print"},{"value":"1432-2072","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,7,1]]},"assertion":[{"value":"14 March 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 June 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 July 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"Drs. Cardozo, Felsovalyi, and Shmelkov are co-founders of GeneCentrix, Inc.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}